Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

fMRI Paradigm Detects Cognitive Impairment in MS

Mult Scler J; ePub 2016 Sep 9; Nelson, Akhtar, et al

Functional magnetic resonance imaging (fMRI) paradigms, such as the immediate/delayed memory task (I/DMT), detect cognitive impairment in multiple sclerosis (MS) patients. Preliminary findings using I/DMT showed differences in blood oxygenation level dependent (BOLD) activation between cognitively impaired MS patients and non-impaired MS patients. A recent study sought to confirm cognitive impairment based on I/DMT BOLD activation in a cohort of 50 MS patients while examining the role of T2 lesion volume and Expanded Disability Status Scale (EDSS) in magnitude of BOLD signal. Researchers found:

  • Analysis of variance showed non-impaired patients had significantly greater working memory activation than impaired patients, in the left prefrontal cortex and left supplementary motor area.
  • Regression analysis showed significant inverse correlations between working memory activation and T2 lesion volume/EDSS in similar areas.

Citation:

Nelson F, Akhtar MS, Zύñiga E, et al. Novel fMRI working memory paradigm accurately detects cognitive impairment in multiple sclerosis. [Published online ahead of print September 9, 2016]. Mult Scler J. doi:10.1177/1352458516666186.